Lloyd Brian G. reported option exercise involving 16,722 derivative units of MERIT MEDICAL SYSTEMS INC at $0.00 for $0 on Nov 16, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
CHIEF LEGAL OFFICER, SECRETARY
CHIEF LEGAL OFFICER, SECRETARY
Filed Nov 17, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
16,722Non-qualified stock options (right to buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Nov 16, 2026Option exercise
Filed
Nov 17, 2026, 12:36 PM ET1-day reporting delay
Accession
0001671772-26-000008Code M · Transaction 402680
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 16, 2026Sell16,722$86.33−$1,443,526.65Trade 402679
Nov 16, 2026Option exercise16,722$37.71$630,586.62Trade 402678
3 transaction rows in this filing. Joint filers share the same rows.

MMSI price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MMSI · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −4.6%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2026. F2: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.88 to $86.90, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3: Become exercisable in equal annual installments of 25% commencing on 02/26/2021. F4: Become exercisable in equal annual installments of 25% commencing on 03/19/2022. F5: Becomes exercisable in equal annual installments of 25% commencing 02/28/2023. F6: Become exercisable in equal annual installments of 25% commencing on 02/28/2024.